Treatment of Obesity

Treatment of Obesity:

“The Role of Liraglutide”

Akram Echtay MD

Professor of Medicine & Endocrinology

Head Division of Endocrinology at LU-Medical School

Chairman of Internal Medicine Department at RHUH

Past President of The Lebanese Society of Endocrinology

Disclosure

- Speaker:

   Novonordisk, Sanofi, AstraZeneca, MSD, Lilly, Boehringer,  Merck, Novartis

- PI in several studies supported by:

   Novonordisk, MSD, Sanofi, Boehringer, AstraZeneca,          Merck, Novartis

Major Problems in The Management of Obesity:

- High Prevalence of obesity

- Complex pathophysiology

- Complications and consequences of obesity

- Economic burden of obesity management

- Barriers for losing weight and maintaining weight loss